Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

0
Danakali continues to progress Eritrean sulphate of potash project towards development

2018-08-02 proactiveinvestors.com.au
Danakali Ltd (ASX:DNK) (LSE:DNK) has achieved significant progress towards the development of its Colluli Potash Project in Eritrea, East Africa during the quarter ended June 30, 2018.
DNKLY SBMSF LNSTY DNK

0
Danakali lists on the London Stock Exchange

2018-07-24 proactiveinvestors.com.au
Australian-based Danakali Limited (ASX:DNK) (LON:DNK) has added London to its listing on the Australian Securities Exchange.
LNSTY DNK

0
Danakali Limited to begin trading on London's Main Market later this month

2018-07-12 proactiveinvestors.com.au
Seamus Cornelius, executive chairman of Danakali Limited (LON:DNK, ASX:DNK), discusses with Proactive's Andrew Scott their intention to begin trading on the London Stock Exchange Main Market around July 24th.
DNKLY SBMSF DNK

0
Danakali gets ready for London Stock Exchange listing

2018-07-12 proactiveinvestors.com.au
Danakali Ltd (ASX:DNK) is getting ready to mark a major milestone by starting to trade on the London Stock Exchange (LSE) main market from 24 July 2018.
DNKLY SBMSF LNSTY DNK

0
Danakali announces new Executive Chairman and CCO as Colluli project advances

2018-06-14 proactiveinvestors.com.au
Danakali Ltd (ASX:DNK) outgoing chief executive Danny Goeman speaks to Proactive Investors about the binding offtake agreement for up to 100% of module I sulphate of potash (SOP) production from the Colluli Potash Project in Eritrea, East Africa.
DNKLY SBMSF DNK

0
Danakali signs offtake deal for full production from Colluli Potash Project

2018-06-12 proactiveinvestors.com.au
Danakali Ltd (ASX:DNK) and its partner have signed a binding offtake agreement for up to 100% of module I sulphate of potash (SOP) production from the Colluli Potash Project in Eritrea, East Africa.
DNKLY SBMSF DNK

0
Danakali prepares to update market on off-take negotiations

2018-06-08 proactiveinvestors.com.au
Danakali Ltd (ASX:DNK) has entered a trading halt today pending the release of commercial information regarding the progress of its off-take negotiations.
DNKLY SBMSF DNK

0
Danakali well-funded to continue execution phase at Colluli Potash Project

2018-04-27 proactiveinvestors.com.au
Danakali Ltd (ASX:DNK) is well-funded to continue the execution phase of the Colluli Potash Project in Eritrea with $16.4 million in cash as at March 31, 2018.
DNKLY SBMSF DNK

0
Danakali’s advanced potash project is a cut above the rest

2018-04-11 proactiveinvestors.com.au
Danakali Ltd (ASX:DNK) is focused on the development of the world-class Colluli Potash Project in the East African country of Eritrea.
DNKLY SBMSF DNK

0
Danakali major shareholder increases interest through option exercise

2018-04-10 proactiveinvestors.com.au
Danakli Ltd (ASX:DNK) has had major shareholder, Well Efficient Ltd, increase its holding to 13.33% in the company.
DNK

0
Danakali poised to develop the world's largest undeveloped sulphate of potash deposit

2018-03-27 proactiveinvestors.com.au
Danakali Ltd’s (ASX:DNK) Colluli Potash Project in the Danakil Depression region of Eritrea, East Africa, is the world’s largest undeveloped sulphate of potash (SOP) deposit.
DNKLY SBMSF DNK

Related Articles

BLDP: Ballard Power Systems Analysis and Research Report

2018-08-13 - Asif

Core Business At Ballard, Ballard Power Systems is building a clean energy growth company. Ballard Power Systems is recognized as a world leader in proton exchange membrane (“PEM”) fuel cell power system development and commercialization. The company's principal business is the design, development, manufacture, sale and service of PEM fuel cell products for a variety of applications, focusing on its power product markets of Heavy-Duty Motive (consisting of bus, truck, rail and marine applications), Portable Power, Material Handling and Backup Power, as well as the delivery of Technology Solutions, including engineering services, technology transfer, and the license and sale of its extensive intellectual property portfolio and fundamental knowledge for a variety of fuel cell applications. A fuel cell is an environmentally clean electrochemical device that combines hydrogen fuel with oxygen (from the air) to produce electricity. The hydrogen fuel can be obtained from natural g...

MARA: Marathon Patent Group Analysis and Research Report

2018-08-13 - Asif

Overview Marathon Patent Group was incorporated in the State of Nevada on February 23, 2010 under the name Verve Ventures, Inc. On December 7, 2011, the company changed its name to American Strategic Minerals Corporation and were engaged in exploration and potential development of uranium and vanadium minerals business. In June 2012, the company discontinued its minerals business and began to invest in real estate properties in Southern California. In October 2012, the company discontinued its real estate business when its former CEO joined the firm and the company commenced its IP licensing operations, at which time the Company’s name was changed to Marathon Patent Group, Inc. On November 1, 2017, the company entered into a merger agreement with Global Bit Ventures, Inc. (“GBV”), which is focused on mining digital assets. Marathon Patent Group has since purchased its cryptocurrency mining machines and established a data center in Canada to mine digital assets. Following the me...

ECYT: Endocyte Analysis and Research Report

2018-08-13 - Asif

Business and Organization Endocyte, Inc. is a biopharmaceutical company and leader in developing targeted therapies for the treatment of cancer. The Company uses drug conjugation technology to create novel therapeutics and companion imaging agents for personalized targeted therapies. The agents actively target receptors that are over-expressed on diseased cells relative to healthy cells, such as prostate specific membrane antigen (“PSMA”) in prostate cancer. This targeted approach is designed to safely enable the delivery of highly potent drug payloads. The companion imaging agents are designed to identify patients whose disease over-expresses the target of the therapy and who are therefore more likely to benefit from treatment. In September 2017, the Company entered into a Development and License Agreement (the “License Agreement”) with ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH (“ABX”), pursuant to which the Company acquired exclusive ...